Table 4.

Differences in QoL across public health PA categories in KCS, Alberta, Canada, May 2010 (N = 703)

CS; n= 396IA; n= 124WG; n= 84AG; n= 99P-differenceP for trend
PWB a22.5 (5.4)24.2 (4.3)24.7 (4.1)24.4 (4.0)<0.001
PWB b22.7 (0.23)23.9 (0.41)24.3 (0.50)24.3 (0.46)= 0.001<0.001
FWB a20.1 (6.0)22.1 (4.9)23.1 (4.9)23.1 (5.2)<0.001
FWB b20.3 (0.28)21.8 (0.49)22.6 (0.60)22.8 (0.55)<0.001<0.001
EWB a19.1 (4.5)19.2 (4.2)20.5 (3.3)19.4 (4.6)0.083
EWBb19.1 (0.21)19.2 (0.38)20.4 (0.46)19.5 (0.42)0.102=0.097
SWB a18.3 (5.7)18.7 (4.8)19.4 (5.0)19.7 (5.0)0.073
SWB b18.2 (0.27)18.8 (0.48)19.4 (0.59)19.7 (0.54)0.059=0.01
Fatigue a35.7 (11.5)39.4 (10.0)42.4 (9.3)42.0 (10.9)<0.001
Fatigueb36.3 (0.54)38.8 (0.94)41.1 (1.16)41.6 (1.06)<0.001<0.001
Kidney symptom indexa45.0 (9.1)48.2 (7.8)50.4 (7.5)48.6 (9.1)<0.001
Kidney symptom indexb45.5 (0.41)47.6 (0.72)49.3 (0.88)48.1 (0.80)<0.001<0.001
FACT-G a80.0 (15.9)84.1 (14.2)87.6 (13.0)86.6 (14.8)<0.001
FACT-G b80.4 (0.74)83.8 (1.29)86.6 (1.59)86.5 (1.45)<0.001<0.001
FACT-F a115.7 (25.1)123.5 (22.7)129.9 (20.6)128.7 (23.3)<0.001
FACT-F b116.7 (1.16)122.6 (2.04)127.7 (2.51)128.1 (2.29)<0.001<0.001
Trial outcome index-fatigue a78.3 (20.2)85.6 (17.5)90.1 (15.7)89.5 (17.7)<0.001
Trial outcome index-fatigue b79.3 (0.91)84.6 (1.60)87.9 (1.97)88.8 (1.80)<0.001<0.001
  • aUnadjusted mean (standard deviation).

  • bAdjusted mean (standard error) is adjusted for age, sex, martial status, education, BMI, months since diagnosis, drug treatment, current treatment status, recurrence, current disease status, smoking, drinking, and number of comorbidities.